Amedisys Inc (NASDAQ:AMED) has coverage initiated with a Equal Weight rating

Analyst Ratings For Amedisys Inc (NASDAQ:AMED)

Story continues below

Today, Barclays initiated coverage on Amedisys Inc (NASDAQ:AMED) with a Equal Weight.

There are 7 Hold Ratings, 6 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Amedisys Inc (NASDAQ:AMED) is Hold with a consensus target price of $109.3333 per share, a potential 15.64% downside.

Some recent analyst ratings include

  • 12/14/2018-Amedisys Inc (NASDAQ:AMED) has coverage initiated with a Equal Weight rating
  • 11/16/2018-Amedisys Inc (NASDAQ:AMED) has coverage initiated with a Neutral ➝ Neutral rating and $126.00 price target
  • 10/30/2018-Amedisys Inc (NASDAQ:AMED) gets upgraded to Buy by Benchmark with a price target of $125.00
  • 10/26/2018-Amedisys Inc (NASDAQ:AMED) gets downgraded to Hold by Craig Hallum with a price target of $104.00
  • On 11/23/2018 David B Pearce, Insider, sold 398 with an average share price of $119.25 per share and the total transaction amounting to $47,461.50.
  • On 11/16/2018 Jake L Netterville, Director, sold 3,394 with an average share price of $122.86 per share and the total transaction amounting to $416,986.84.
  • On 11/14/2018 Michael Paul North, Insider, sold 5,625 with an average share price of $117.57 per share and the total transaction amounting to $661,331.25.
  • On 11/12/2018 Michael Paul North, Insider, sold 2,264 with an average share price of $119.30 per share and the total transaction amounting to $270,095.20.
  • On 11/12/2018 Scott G. Ginn, CFO, sold 7,640 with an average share price of $117.41 per share and the total transaction amounting to $897,012.40.
  • On 11/9/2018 Christopher Gerard, COO, sold 7,892 with an average share price of $119.02 per share and the total transaction amounting to $939,305.84.
  • On 11/9/2018 David L. Kemmerly, Insider, sold 6,500 with an average share price of $118.87 per share and the total transaction amounting to $772,655.00.

About Amedisys Inc (NASDAQ:AMED)
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks. The Hospice segment offers care that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer's, HIV/AIDS, and cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 27, 2018, the company owned and operated 421 care centers in 34 states. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.

Recent Trading Activity for Amedisys Inc (NASDAQ:AMED)
Shares of Amedisys Inc closed the previous trading session at 129,60 −3,17 2,39 % with 128.04 shares trading hands.

An ad to help with our costs